IP Verse

Wittkopp patent opposition analysis

The comprehensive analysis of Wittkopp opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Wittkopp

Stay updated with the latest patent oppositions filed by Wittkopp

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3272738
Processes For Preparing Jak Inhibitors And Related Intermediate CompoundsINCYTEAug 12, 2025HAMM & WITTKOPP
EP4321157
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025ALFRED E TIEFENBACHER
EP3784283
Cannabidiol Preparations And Its UsesJAZZ PHARMACEUTICALS RESEARCH UKJul 22, 2025HAMM & WITTKOPP
EP3242666
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 15, 2025SYNTHON
EP3226841
Anticancer CompositionsARAGON PHARMACEUTICALSJul 7, 2025HAMM & WITTKOPP
EP4125903
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 1, 2025STADA ARZNEIMITTEL
EP4097091
Solid State Forms Of Mavacamten And Process For Preparation ThereofASSIA CHEMICAL INDUSTRIESJun 18, 2025HAMM & WITTKOPP
EP4084779
Compositions Of 1-(4-Bromo-5-(1-Ethyl-7-(Methylamino)-2-Oxo-1,2-Dihydro-1,6-Naphthyridin-3-Yl)-2-Fluorophenyl)-3-PhenylureaDECIPHERA PHARMACEUTICALSMay 28, 2025ALFRED E TIEFENBACHER
EP3801459
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 7, 2025SYNTHON
EP3439662
Liquid Formulations Of (S)-N-(5-((R)-2-(2,5-Difluorophenyl)-Pyrrolidin-1-Yl)-Pyrazolo[1,5-A]Pyrimidin-3-Yl)-3-Hydroxypyrrolidine-1-CarboxamideLOXO ONCOLOGYApr 11, 2025SYNTHON

Top clients of Wittkopp

Top companies who are the clients of Wittkopp

CompanyTotal
STADA ARZNEIMITTEL71
HAMM & WITTKOPP52
ALFRED E TIEFENBACHER41
SYNTHON20
BETAPHARM ARZNEIMITTEL11
POLPHARMA9
WITTKOPP9
TEVA PHARMACEUTICALS4
ALVOGEN IPCO3
G L PHARMA3